CDEK
← All drugs Report issue

abp-700

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2016 (NCT02800590)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COC(=O)C1(OC(=O)c2cncn2[C@H](C)c2ccccc2)CC1
Mol. weight
314.34 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • abp-700
  • abp-700

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02800590Phase 2May 1, 2016The Medicines Company, University of Groningen
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
The Medicines CompanyFor profit1112016
University of GroningenAcademic/Hospital1012016
2 organizations
Page 1 / 1